Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $9.2300 (8.84%) ($9.2300 - $9.2400) on Wed. Mar. 16, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.95% (three month average) | RSI | 23 | Latest Price | $9.2300(8.84%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.2% a day on average for past five trading days. | Weekly Trend | ATRA declines -13.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(50%) IBB(47%) ARKG(46%) ARKK(46%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -2.475% in a week (0% probabilities). VIXM(-40%) VXX(-29%) UNG(-17%) EDOC(-13%) USO(-9%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.475% (StdDev 4.95%) | Hourly BBV | 2.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-25.43(-375.51%) | Resistance Level | $10.68 | 5 Day Moving Average | $8.88(3.94%) | 10 Day Moving Average | $8.94(3.24%) | 20 Day Moving Average | $10.68(-13.58%) | To recent high | -46.6% | To recent low | 9.4% | Market Cap | $686m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |